Circadian Clock Controls Sugar Metabolism

The body’s circadian rhythm has more of an effect on glucose tolerance than one’s eating and sleeping patterns, a study shows.

Written byAnna Azvolinsky
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, JACOB TOORNVLIET's 'THE SLEEPING WOMAN' Humans’ 24-hour circadian clock plays a leading role in glucose tolerance, according to a study published Moday (April 13) in PNAS. Researchers in Boston have found that, because of body’s circadian rhythm, human glucose tolerance is reduced during the evening hours, even when “day” and “night” times are experimentally reversed.

“In a prior [human] study, we found that when behavior cycles of feeding and sleeping are not in normal alignment with the internal body clock, that this negatively affects the regulation of blood sugar and especially glucose tolerance,” said neuroscientist Frank Scheer from the Division of Sleep and Circadian Disorders at the Brigham and Women’s Hospital in Boston. People who work night shifts are more prone to type 2 diabetes and obesity, he noted.

In an attempt to understand the independent effects of eating and sleeping behaviors versus the circadian clock on glucose tolerance, Scheer and his colleagues mimicked night-shift work in 14 healthy individuals under controlled laboratory conditions. Participants spent eight days on a typical day-shift schedule, eating breakfast at 8:00 a.m., dinner at ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • head shot of blond woman wearing glasses

    Anna Azvolinsky received a PhD in molecular biology in November 2008 from Princeton University. Her graduate research focused on a genome-wide analyses of genomic integrity and DNA replication. She did a one-year post-doctoral fellowship at Memorial Sloan Kettering Cancer Center in New York City and then left academia to pursue science writing. She has been a freelance science writer since 2012, based in New York City.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies